These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32934884)

  • 41. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
    Gupta S; Yeh S; Chami R; Punnett A; Chung C
    Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
    Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
    Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Hodgkin and Reed/Sternberg cell.
    Küppers R; Hansmann ML
    Int J Biochem Cell Biol; 2005 Mar; 37(3):511-7. PubMed ID: 15618006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis.
    Piris MA; Medeiros LJ; Chang KC
    Pathology; 2020 Jan; 52(1):154-165. PubMed ID: 31699300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Immune System Alterations in Hodgkin Lymphoma.
    Grover NS; Savoldo B
    Curr Hematol Malig Rep; 2017 Aug; 12(4):358-369. PubMed ID: 28780614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in mice.
    Engert A; Gottstein C; Bohlen H; Winkler U; Schön G; Manske O; Schnell R; Diehl V; Thorpe P
    Int J Cancer; 1995 Oct; 63(2):304-9. PubMed ID: 7591221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
    Yurchenko M; Sidorenko SP
    Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrafast Papanicolaou stain and cell-transfer technique enhance cytologic diagnosis of Hodgkin lymphoma.
    Zu Y; Gangi MD; Yang GC
    Diagn Cytopathol; 2002 Nov; 27(5):308-11. PubMed ID: 12411999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cells.
    Rengstl B; Schmid F; Weiser C; Döring C; Heinrich T; Warner K; Becker PS; Wistinghausen R; Kameh-Var S; Werling E; Billmeier A; Seidl C; Hartmann S; Abken H; Küppers R; Hansmann ML; Newrzela S
    Oncoimmunology; 2016 Jun; 5(6):e1160186. PubMed ID: 27471632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
    Roemer MGM; Redd RA; Cader FZ; Pak CJ; Abdelrahman S; Ouyang J; Sasse S; Younes A; Fanale M; Santoro A; Zinzani PL; Timmerman J; Collins GP; Ramchandren R; Cohen JB; De Boer JP; Kuruvilla J; Savage KJ; Trneny M; Ansell S; Kato K; Farsaci B; Sumbul A; Armand P; Neuberg DS; Pinkus GS; Ligon AH; Rodig SJ; Shipp MA
    J Clin Oncol; 2018 Apr; 36(10):942-950. PubMed ID: 29394125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma.
    Hansen HP; Paes Leme AF; Hallek M
    Front Immunol; 2020; 11():398. PubMed ID: 32296414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.
    Tang H; Wei Q; Ge J; Jian W; Liu J; Zhong L; Fu B; Zhao T
    Hum Pathol; 2013 Oct; 44(10):2167-72. PubMed ID: 23845468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hodgkin's lymphoma and CD30 signal transduction.
    Horie R; Higashihara M; Watanabe T
    Int J Hematol; 2003 Jan; 77(1):37-47. PubMed ID: 12568298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma.
    Hollander P; Ginman B; Molin D; Enblad G; Amini RM; Glimelius I
    Immunobiology; 2020 Jan; 225(1):151872. PubMed ID: 31787352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD30 antigen and cellular biology of Reed-Sternberg cells.
    Pizzolo G; Vinante F; Chilosi M; Romagnani S; Del Prete G
    Blood; 1994 Dec; 84(11):3983-4. PubMed ID: 7949157
    [No Abstract]   [Full Text] [Related]  

  • 60. Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment.
    Ferrarini I; Rigo A; Zamò A; Vinante F
    Leuk Lymphoma; 2019 Dec; 60(14):3395-3405. PubMed ID: 31304817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.